Peroxisome proliferator-activated receptor-beta as a target for wound healing drugs.

Détails

ID Serval
serval:BIB_36565944F9B0
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Institution
Titre
Peroxisome proliferator-activated receptor-beta as a target for wound healing drugs.
Périodique
Expert Opinion on Therapeutic Targets
Auteur⸱e⸱s
Tan N.S., Michalik L., Desvergne B., Wahli W.
ISSN
1744-7631 (Electronic)
ISSN-L
1472-8222
Statut éditorial
Publié
Date de publication
2004
Peer-reviewed
Oui
Volume
8
Numéro
1
Pages
39-48
Langue
anglais
Résumé
Healing of cutaneous wounds, which is crucial for survival after an injury, proceeds via a well-tuned pattern of events including inflammation, re-epithelialisation, and matrix and tissue remodelling. These events are regulated spatio-temporally by a variety of growth factors and cytokines. The inflammation that immediately follows injury increases the expression of peroxisome proliferator-activated receptor (PPAR)-beta in the wound edge keratinocytes and triggers the production of endogenous PPARbeta ligands that activate the newly produced receptor. This elevated PPARbeta activity results in increased resistance of the keratinocytes to the apoptotic signals released during wounding, allowing faster re-epithelialisation. The authors speculate that, in parallel, ligand activation of PPARbeta in infiltrated macrophages attenuates the inflammatory response, which also promotes repair. Thus, current understanding of the roles of PPARbeta in different cell types implicated in tissue repair has revealed an intriguing intercellular cross-talk that coordinates, spatially and temporally, inflammation, keratinocyte survival, proliferation and migration, which are all essential for efficient wound repair. These novel insights into the orchestrating roles of PPARbeta during wound healing may be helpful in the development of drugs for acute and chronic wound disorders.
Mots-clé
Administration, Topical, Animals, Apoptosis/drug effects, Apoptosis/physiology, Cytokines/physiology, Drug Design, Gene Expression Regulation/drug effects, Gene Expression Regulation/physiology, Growth Substances/physiology, Humans, Inflammation, Keratinocytes/cytology, Keratinocytes/drug effects, Lipid Metabolism/drug effects, Macrophages/physiology, Mice, Models, Biological, PPAR-beta/agonists, PPAR-beta/physiology, Psoriasis/drug therapy, Psoriasis/metabolism, Skin/injuries, Wound Healing/drug effects, Wound Healing/physiology
Pubmed
Web of science
Création de la notice
24/01/2008 16:27
Dernière modification de la notice
20/08/2019 14:24
Données d'usage